BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
102.14
-4.26 (-4.00%)
Nov 20, 2024, 4:00 PM EST - Market open
BioNTech SE Stock Forecast
Stock Price Forecast
The 13 analysts with 12-month price forecasts for BioNTech SE stock have an average target of 139.46, with a low estimate of 122 and a high estimate of 171. The average target predicts an increase of 36.54% from the current stock price of 102.14.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BioNTech SE stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 5 | 6 | 7 |
| Buy | 1 | 1 | 1 | 2 | 2 | 3 |
| Hold | 6 | 6 | 6 | 7 | 6 | 3 |
| Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 14 | 14 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Hold → Buy Upgrades $110 → $125 | Hold → Buy | Upgrades | $110 → $125 | +22.38% | Nov 19, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $171 | Strong Buy | Maintains | $171 | +67.42% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $150 | Strong Buy | Reiterates | $150 | +46.86% | Nov 18, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $171 | Strong Buy | Maintains | $171 | +67.42% | Nov 14, 2024 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $90 → $137 | Hold → Strong Buy | Upgrades | $90 → $137 | +34.13% | Nov 8, 2024 |
Financial Forecast
Revenue This Year
2.68B
from 3.82B
Decreased by -29.85%
Revenue Next Year
2.65B
from 2.68B
Decreased by -1.12%
EPS This Year
-3.03
from 3.83
EPS Next Year
-3.47
from -3.03
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.1B | 3.6B | 3.6B | ||
| Avg | 2.7B | 2.6B | 2.7B | ||
| Low | 2.4B | 1.8B | 1.7B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -17.8% | 35.5% | 34.2% | ||
| Avg | -29.9% | -1.1% | 0.9% | ||
| Low | -38.4% | -33.7% | -34.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.35 | -0.80 | 1.45 | ||
| Avg | -3.03 | -3.47 | -2.69 | ||
| Low | -5.64 | -7.37 | -6.77 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.